Health

India’s Covaxin Found To Offer 77.8 Percent Protection Against COVID-19: Study

GENEVA, Nov 12 — Data from Phase 3 trials of the coronavirus vaccine Covaxin, developed in India, has shown that two doses offer 77.8 per cent protection against COVID-19, according to findings published Thursday in The Lancet medical journal.

Covaxin, known by the code BBV152, is an inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology.

The drug on Nov 3 was granted emergency use approval by the World Health Organisation (WHO) for adults 18 years and older and is the eighth jab to be given the green light by the health body.

The WHO determined that Covaxin met its standards for protection against COVID-19 and “that the benefit of the vaccine far outweighs risks.”

It recommended the vaccine be administered in two doses, with an interval of four weeks in age groups 18 and above, reported Anadolu Agency.

The jab has not been advised for pregnant women as available data is “insufficient” to “assess vaccine safety or efficacy in pregnancy.”

Other COVID-19 vaccines approved by the specialised UN agency are Pfizer-BioNTech, Oxford-AstraZeneca, Johnson & Johnson’s Janssen, Moderna, Sinopharm, and Sinovac.

The Phase 3 trials ran from Nov 16, 2020 until May 17, 2021, and included participants between 18 and 97 years old, said the article in the scientific journal.

Trial participants were given two doses of either Covaxin or a placebo.

Participants considered at high risk for COVID-19 infection were prioritised, with 2,750 participants above 60 years of age and 5,724 participants with at least one preexisting condition included in the study.

Participants were recruited from 25 hospitals across India for geographic diversity.

Covaxin “was well-tolerated by all trial participants; 12 per cent of both groups reported an adverse event, with no significant difference in the number of events between the placebo and BBV152 groups,” said the findings.

Sources: BERNAMA

Adib Mohd

Recent Posts

Tourism Malaysia And Merchantrade Join Forces To Power “Visit Malaysia 2026–2027”

In a definitive move to elevate Malaysia’s tourism economy ahead of the Visit Malaysia 2026–2027… Read More

11 hours ago

BattleKart Brings Real-Life Video Game Racing to KL, Alongside Slim Chickens’ New Outlet

What if you could step inside a video game and race your friends in real… Read More

14 hours ago

Xiaomi Unveils New Wearables In Malaysia, Including Smartwatches & Its First Clip-On Earbuds

Xiaomi has introduced three new wearables in Malaysia, offering more options for fitness tracking, everyday… Read More

14 hours ago

Xiaomi Introduces 5 New Mijia Appliances To Make Everyday Household Chores Easier

Xiaomi has expanded its smart home lineup with several new Mijia appliances designed to simplify… Read More

15 hours ago

Xiaomi 18 Pro Series Arrives In Malaysia With Back Display, Dual 200MP Cameras & AI Features

Xiaomi has introduced its latest flagship smartphones, the Xiaomi 18 Pro and Xiaomi 18 Pro… Read More

15 hours ago

Don’t Throw Away Your Thermal Bags! Get Creative & Turn Into Something Else

If you've ever ordered takeaway drinks from popular franchises like CHAGEE, ZUS Coffee or Coffee… Read More

20 hours ago

This website uses cookies.